People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clade Therapeutics, Inc. | — | Pharmaceuticals | Series C | $45.9M | $1.1B | 2021 |
Jim A. Glasheen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jim A. Glasheen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Leandro A. Vetcher | 1 | 1 |
| Daniel A. Vasella | 1 | 1 |
| Neil A. White | 1 | 1 |
| Chad A. Cowan | 1 | 1 |
| Martin A. Murphy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.